1. Contractors
  2. Institute for Clinical Pharmacodynamics, Inc.

Institute for Clinical Pharmacodynamics, Inc.

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Institute for Clinical Pharmacodynamics has 4 federal contracts of $100,000 or more active since October 2023, with $948K obligated, from 2 agencies. 2 are still running, 1 ending within 18 months.

Contracts
4 since FY2024$947,650 obligated, contracts of $100,000 or more
Running now
2 contracts
Biggest customer
Food and Drug Administration$837K on 3 contracts
UEI
Z82HHPY83MC7Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2023$263,016
FY2024$248,553
FY2026$436,080

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Baa Contract - Development of Susceptibility Guidance for Daptomycin and Enterococcus Species Using Pharmacometric ApproachesFood and Drug Administration · 75F40126C00025$325,000Jul 31, 2027in 8 monthsNY
C02 - Pk-Pd Analysis of Mouse Model Efficacy and Pk Data for Antibacterial CompoundsNational Institutes of Health · 75N93026F00001$111,080Jul 14, 2031in 55 monthsNY

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Food and Drug Administration3 contracts$836,570
National Institutes of Health1 contract$111,080

Where the work is

Place of workAmount
New York4 contracts$947,650

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Food and Drug Administration: see the list.

Get new notices like Institute for Clinical Pharmacodynamics's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy